A detailed history of Superstring Capital Management LP transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 599,048 shares of TNGX stock, worth $1.82 Million. This represents 4.04% of its overall portfolio holdings.

Number of Shares
599,048
Previous 115,571 418.34%
Holding current value
$1.82 Million
Previous $992 Million 365.17%
% of portfolio
4.04%
Previous 1.25%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.36 - $11.93 $3.56 Million - $5.77 Million
483,477 Added 418.34%
599,048 $4.61 Billion
Q2 2024

Aug 14, 2024

BUY
$6.66 - $10.15 $769,702 - $1.17 Million
115,571 New
115,571 $992 Million

Others Institutions Holding TNGX

About Tango Therapeutics, Inc.


  • Ticker TNGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,067,296
  • Market Cap $268M
  • Description
  • Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...
More about TNGX
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.